We took advantage of Elevance Health's share price weakness in the fourth quarter and added modestly to our investment. Click here to read more.

Fever fans welcome a new $78 million performance facility, one of the first in the WNBA. But others question how the ...

Shares of Elevance Health Inc. ELV shed 1.26% to $400.30 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.47% to 6,039.31 ...

Elevance Health Inc (ELV) stock saw a decline, ending the day at $405.4 which represents a decrease of $-5.84 or -1.42% from the prior close of $411.24. The stock opened at $410.18 and touched a low ...

Elevance Health Inc. closed 27.50% below its 52-week high of $567.26, which the company achieved on September 3rd.

After a dip in the wake of the release of UnitedHealth Group's Q4 2024 earnings figures, shares in the company and other ...

In a report released today, Andrew Mok CFA from Barclays maintained a Buy rating on Elevance Health (ELV – Research Report), with a price ...

Mark Kaye, the chief financial officer, said the company took a "very disciplined approach between competitiveness and underwriting." ...

Mark Kaye, the chief financial officer, said the company took a "very disciplined approach between competitiveness and underwriting." ...

Operator instructions] As a reminder, today's conference is being recorded. I would now like to turn the conference over to ...